Home > News > WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
March 26th, 2004
WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
WallStreet Research led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an analyst research report initiating coverage of BioSante Pharmaceuticals, Inc. The complete analyst research report on BioSante Pharmaceuticals, Inc., together with the risks associated therewith and additional information about WallStreet Research is available online.
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014
Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014